Langerhans cell histiocytosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
}}
}}
{{Langerhans cell histiocytosis}}
{{Langerhans cell histiocytosis}}
{{CMG}}
{{CMG}};{{AE}} {{KS}}


{{SK}} Histiocytosis X; histiocytosis X syndrome; Hand-Schüller-Christian disease; Letterer-Siwe disease; histiocytosis X; eosinophilic granulomatosis unspecified; Langerhans cell granulomatosis; Langerhans cell histiocytosis-Hashimoto-Pritzker type; Langerhans cell histiocytosis, disseminated (clinical); Langerhans cell histiocytosis, unifocal (clinical); Langerhans cell histiocytosis of the lung; non-lipid reticuloendotheliosis; eosinophilic granuoloma; pulmonary histiocytosis X; pulmonary Langerhans cell granulomatosis
{{SK}} Histiocytosis X; histiocytosis X syndrome; Hand-Schüller-Christian disease; Letterer-Siwe disease; histiocytosis X; eosinophilic granulomatosis unspecified; Langerhans cell granulomatosis; Langerhans cell histiocytosis-Hashimoto-Pritzker type; Langerhans cell histiocytosis, disseminated (clinical); Langerhans cell histiocytosis, unifocal (clinical); Langerhans cell histiocytosis of the lung; non-lipid reticuloendotheliosis; eosinophilic granuoloma; pulmonary histiocytosis X; pulmonary Langerhans cell granulomatosis

Revision as of 13:31, 8 September 2014

For patient information, click here Template:DiseaseDisorder infobox

Langerhans cell histiocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Langerhans cell histiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Langerhans cell histiocytosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Langerhans cell histiocytosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Langerhans cell histiocytosis

on Langerhans cell histiocytosis

Langerhans cell histiocytosis in the news

Blogs on Langerhans cell histiocytosis

Directions to Hospitals Treating Langerhans cell histiocytosis

Risk calculators and risk factors for Langerhans cell histiocytosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Synonyms and keywords: Histiocytosis X; histiocytosis X syndrome; Hand-Schüller-Christian disease; Letterer-Siwe disease; histiocytosis X; eosinophilic granulomatosis unspecified; Langerhans cell granulomatosis; Langerhans cell histiocytosis-Hashimoto-Pritzker type; Langerhans cell histiocytosis, disseminated (clinical); Langerhans cell histiocytosis, unifocal (clinical); Langerhans cell histiocytosis of the lung; non-lipid reticuloendotheliosis; eosinophilic granuoloma; pulmonary histiocytosis X; pulmonary Langerhans cell granulomatosis

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Langerhans cell histiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History amd Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related chapters

Resources

Template:Hematology


Template:WikiDoc Sources